The inhibitory effect of preoperative immunochemotherapy on the lymph node metastasis of murine MM48 tumor.
A murine tumor model showing metastases to lymph nodes (LN) was established by intradermally implanting highly metastatic MM48 tumor cells (2 x 10(6)) in C3H/HeN mice. We were searching for the most effective immunochemotherapeutic modality to treat this metastatic tumor. The combination therapy with chemotherapeutics, granulocyte colony-stimulating factor (G-CSF) and OK-432 on Days 8-11 was found to be remarkably effective, making the solid tumor disappear in more than half of the treated mice, though all of them eventually died of LN metastasis, as all the control mice did. Then an attempt was made to cure the mice from such fatal metastatic tumors with combined immunochemotherapy prior to surgical resection on Day 14. The combination therapy with chemotherapeutics, G-CSF and OK-432 more strongly inhibited the metastases then, and more than 85% of the mice survived. When the survivors were rechallenged with MM48 tumor cells, all of them rejected and survived without recurrences and metastases, indicating the acquirement of specific immunity. It is expected that this preoperative immunochemotherapy may be clinically useful for the treatment of malignant neoplasms.
Central Research Laboratories, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
C
C
Kudo
M
M
Saito
T
T
Yoshida
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004195:Disease Models, Animal; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D007167:Immunotherapy; D008207:Lymphatic Metastasis / Q000517:prevention & control*; D008325:Mammary Neoplasms, Experimental / Q000276:immunology / Q000556:secondary* / Q000628:therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D010844:Picibanil / Q000008:administration & dosage
D016179:Granulocyte Colony-Stimulating Factor; D010844:Picibanil